| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 9.674 | - | 21.275 | 91.702 | 8.640 | 0 |
| Total Income - EUR | - | - | - | 4.245 | 17.389 | - | 21.275 | 91.702 | 13.313 | 0 |
| Total Expenses - EUR | - | - | - | 22.666 | 26.961 | - | 23.805 | 57.492 | 8.488 | 0 |
| Gross Profit/Loss - EUR | - | - | - | -18.421 | -9.572 | - | -2.530 | 34.209 | 4.825 | 0 |
| Net Profit/Loss - EUR | - | - | - | -18.439 | -9.669 | - | -2.977 | 31.599 | 3.886 | 0 |
| Employees | - | - | - | 2 | 2 | - | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Ornellamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 38.082 | 32.474 | - | 22.975 | 16.797 | 12.026 | 20.138 |
| Current Assets | - | - | - | 3.342 | 2.325 | - | 15.780 | 4.500 | 4.234 | 3.665 |
| Inventories | - | - | - | 0 | 0 | - | 0 | 0 | 0 | 594 |
| Receivables | - | - | - | 2.584 | 948 | - | 0 | 1.014 | 0 | 1 |
| Cash | - | - | - | 758 | 1.376 | - | 15.780 | 3.486 | 4.234 | 3.070 |
| Shareholders Funds | - | - | - | -14.335 | -22.695 | - | -45.060 | 3.565 | 3.934 | -15.657 |
| Social Capital | - | - | - | 43 | 42 | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 17.026 | 25.412 | - | 54.209 | 922 | 239 | 19.697 |
| Income in Advance | - | - | - | 38.733 | 32.081 | - | 29.607 | 16.810 | 12.087 | 19.763 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Ornellamed Srl